GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » InventisBio Co Ltd (SHSE:688382) » Definitions » EV-to-Revenue

InventisBio Co (SHSE:688382) EV-to-Revenue : 15.42 (As of Jun. 06, 2024)


View and export this data going back to 2022. Start your Free Trial

What is InventisBio Co EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, InventisBio Co's enterprise value is ¥2,994.2 Mil. InventisBio Co's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 was ¥194.1 Mil. Therefore, InventisBio Co's EV-to-Revenue for today is 15.42.

The historical rank and industry rank for InventisBio Co's EV-to-Revenue or its related term are showing as below:

SHSE:688382' s EV-to-Revenue Range Over the Past 10 Years
Min: 15.1   Med: 50.91   Max: 85.82
Current: 15.25

During the past 6 years, the highest EV-to-Revenue of InventisBio Co was 85.82. The lowest was 15.10. And the median was 50.91.

SHSE:688382's EV-to-Revenue is ranked worse than
62.91% of 1038 companies
in the Biotechnology industry
Industry Median: 7.985 vs SHSE:688382: 15.25

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-06-06), InventisBio Co's stock price is ¥7.84. InventisBio Co's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was ¥0.34. Therefore, InventisBio Co's PS Ratio for today is 23.33.


InventisBio Co EV-to-Revenue Historical Data

The historical data trend for InventisBio Co's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

InventisBio Co EV-to-Revenue Chart

InventisBio Co Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-Revenue
Get a 7-Day Free Trial - - - - 36.64

InventisBio Co Quarterly Data
Dec18 Dec19 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 73.27 46.62 36.64 20.44

Competitive Comparison of InventisBio Co's EV-to-Revenue

For the Biotechnology subindustry, InventisBio Co's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


InventisBio Co's EV-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, InventisBio Co's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where InventisBio Co's EV-to-Revenue falls into.



InventisBio Co EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

InventisBio Co's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=2994.197/194.133
=15.42

InventisBio Co's current Enterprise Value is ¥2,994.2 Mil.
InventisBio Co's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥194.1 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


InventisBio Co  (SHSE:688382) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

InventisBio Co's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=7.84/0.336
=23.33

InventisBio Co's share price for today is ¥7.84.
InventisBio Co's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0.34.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


InventisBio Co EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of InventisBio Co's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


InventisBio Co (SHSE:688382) Business Description

Traded in Other Exchanges
N/A
Address
No. 4, Lane 67, Li Bing Road, Room 210, Pilot Free Trade Zone, Shanghai, CHN, 201203
InventisBio Co Ltd is an innovative drug research and development enterprise based in China with a global perspective, focusing on major diseases such as tumors and metabolic diseases. It has independently developed a series of innovative targeted drugs with patent protection, covering non-small cell lung cancer, breast cancer, colorectal cancer and other solid tumors, as well as hyperuricemia and metabolic diseases such as gout.

InventisBio Co (SHSE:688382) Headlines

No Headlines